Use of the Pfizer Pentavalent Meningococcal Vaccine Among Persons Aged ≥10 Years: Recommendations of the Advisory Committee on Immunization Practices ― United States, 2023
by from Morbidity and Mortality Weekly Report (MMWR) on (#6M63R)
This report describes recommendations for using Pfizer pentavalent meningococcal vaccines among people ages 10 years and older.